Advertisement
Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 

Cover Image   
box In this Issue
  arrow Articles
  arrow Brief Communications
  arrow Academia and Clinic
  arrow Reviews
  arrow Perspectives
  arrow Editorials
  arrow Letters
  arrow Medical Writings: Book Notes
  arrow Current Clinical Issues
  arrow Ancillary Content
  arrow Summaries for Patients
  arrow PDF of Contents
box Services
  arrow Subscribe
  arrow One-time access
  arrow Activate online subscription
  arrow Access Personal Archive
 
box In this Issue
  arrow Articles
  arrow Brief Communications
  arrow Academia and Clinic
  arrow Reviews
  arrow Perspectives
  arrow Editorials
  arrow Letters
  arrow Medical Writings: Book Notes
  arrow Current Clinical Issues
  arrow Ancillary Content
  arrow Summaries for Patients
  arrow PDF of Contents
box Services
  arrow Subscribe
  arrow One-time access
  arrow Activate online subscription
  arrow Access Personal Archive
 

TABLE OF CONTENTS

15 May 2001 Volume 134 Issue 10
< Previous Issue  |  Next Issue >
Clear

Articles Back

David Hunt, Peta Young, John Simes, Wendy Hague, Stewart Mann, Dwain Owensby, Geoffrey Lane, Andrew Tonkin for the LIPID Investigators

In older patients with coronary heart disease and average or moderately elevated cholesterol levels, pravastatin therapy reduced the risk for all major cardiovascular events and all-cause mortality. Since older patients are at higher risk than younger patients for these events, the absolute benefit of treatment is significantly greater in older patients.

Abstract | Full Text | PDF | Summary for Patients

Amar A. Sethi, Anne Tybjærg-Hansen, Marie-Louise Moes Grønholdt, Rolf Steffensen, Peter Schnohr, and Børge G. Nordestgaard

In six large case–control studies, the M235T and T174M angiotensinogen mutations were not consistently associated with increased (or decreased) risk for ischemic heart disease, myocardial infarction, or ischemic cerebrovascular disease. Statistically significant associations may represent chance findings rather than real phenomena.

Abstract | Full Text | PDF | Summary for Patients

Donald A. Redelmeier and Sheldon M. Singh

The association of high status with increased longevity that prevails in the public also extends to celebrities, contributes to a large survival advantage, and is partially explained by factors related to success.

Abstract | Full Text | PDF | Summary for Patients


Brief Communications Back

Shoji Kubo, Shuhei Nishiguchi, Kazuhiro Hirohashi, Hiromu Tanaka, Taichi Shuto, Osamu Yamazaki, Susumu Shiomi, Akihiro Tamori, Hiroko Oka, Sumito Igawa, Tetsuo Kuroki, and Hiroaki Kinoshita

Postoperative interferon-{alpha} therapy appears to decrease recurrence of cancer after resection of hepatitis C virus–related hepatocellular carcinoma.

Abstract | Full Text | PDF | Summary for Patients


Academia and Clinic Back

Honghu Liu, Carol E. Golin, Loren G. Miller, Ron D. Hays, C. Keith Beck, Sam Sanandaji, Judith Christian, Tomasa Maldonado, Dena Duran, Andrew H. Kaplan, and Neil S. Wenger

This study examined the relationship between a composite score of three measures of drug adherence and HIV virologic response. The authors found that different measures applied to the same patient suggest different levels of adherence. Adherence may be underestimated by an electronic measurement device and may be overestimated by pill count and interview. A summary measure is more strongly related to a clinical response, but more practical measurement methods are needed for clinical use.

Abstract | Full Text | PDF


Reviews Back

Christine M. Hogan and Scott M. Hammer

This paper, the second of two reviewing the role of host factors in HIV infection, discusses the role of genetic host factors—inheritance of mutant chemokine receptors or ligands as well as HLA type—in susceptibility to infection with HIV and subsequent clinical course. The effects of soluble inhibitory factors, the cytokine milieu, and concomitant infections are also described.

Abstract | Full Text | PDF


Perspectives Back

Eric B. Larson

The instability of today's medical marketplace makes the future of general internal medicine uncertain. To thrive, general internal medicine must build on its strengths within the medical marketplace, seize the opportunities offered by demographic changes, and take a primary role in serving the needs of older patients with chronic diseases.

Abstract | Full Text | PDF


Editorials Back

Ray Fitzpatrick

Accumulating evidence suggests that social status itself, regardless of associated material and economic advantages, may confer health benefits. In this issue, Redelmeier and Singh provide further intriguing evidence by showing that actors and actresses who win Academy Awards live an average of 3.9 years longer than comparable performers who were nominated for an award but did not win.

Full Text | PDF

Barbara J. Turner and Frederick M. Hecht

Liu and colleagues' article in this issue contributes to the field of adherence measurement by showing improved predictive validity after incorporation of data from several adherence measures when data from an electronic monitor were missing. At this point, patient interview remains the most practical approach for clinicians, while a combination of adherence measures seems to be optimal for research purposes.

Full Text | PDF


Letters Back

Efficacy and Safety of Troglitazone for Lipodystrophy Syndromes

Who Discovered Circulation of Blood?

Research Training in Subspecialty Programs

Billie Belle



Medical Writings: Book Notes Back

Nicholas J. Lekas

Full Text | PDF

Michael C. Perry

Full Text | PDF


Current Clinical Issues  Back

Brigid Kane

Full Text | PDF

Doris Margolis

Full Text | PDF


Ancillary Content Back

Full Text | PDF

Full Text | PDF


Summaries for Patients Back

Full Text | PDF

Full Text | PDF

Full Text | PDF

Full Text | PDF



 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 2008 by the American College of Physicians.